NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Novalis Biotech

Novalis Biotech

Belgiumnoval.is

Overview

Novalis Biotech is a Belgium-based early-stage venture capital firm that invests in enabling technologies within the life sciences, including genomics, bioinformatics, diagnostics, and digital health.

Year Founded

2018

Portfolio Companies

10

Website

noval.is

Investments

Novalis Biotech investments
CompanyDateStageLead
Alithea GenomicsMar 2026SeedCo-investor
AltavoJan 2026Series A ExtensionLead
EpilogJun 2025Series A ExtensionLead
Rarity BioscienceJun 2024VC RoundCo-investor
Alithea GenomicsMar 2024SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBelgium
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.